1. At a Glance – ICU Monitor Beeping Green or Flashing Red?
₹69,532 Cr market cap.
₹921 stock price.
69x P/E.
7.37x Price-to-Book.
Q3 FY26 revenue ₹2,265 Cr (+17.5% YoY).
Operating EBITDA ₹505 Cr (22.3% margin).
Net debt ₹2,547 Cr.
Ladies and gentlemen, welcome to the premium healthcare ward.
Fortis Healthcare is not your neighborhood clinic with a stethoscope and one tired doctor. This is a 36-facility empire spanning India, Nepal, Dubai, and Sri Lanka. It runs 33 hospitals, controls diagnostics through Agilus, and is building capacity like a startup that just discovered venture capital.
But here’s the drama — revenue is growing at 17.5% YoY, margins are expanding, and EBITDA looks healthy. Yet reported PAT dropped to ₹197 Cr due to one-offs. Meanwhile, debt is rising because they’re buying hospitals like Pokémon cards.
And the market? It’s charging you 69 times earnings.
So the big question:
Are we looking at India’s next healthcare compounding machine — or a premium stock priced like it already cured cancer?
Let’s scrub in.
2. Introduction – From Controversy to Corporate Comeback
Fortis was born in 1996. First hospital in Mohali, 2001. Then came expansion, drama, promoter chaos, debt, litigations, and finally — a corporate rescue.
The original promoters’ stake shrank from 34% to less than 1% after financial troubles. In 2018, IHH Healthcare stepped in, infused ~₹4,000 Cr, and took control.
That was the turning point.
Since then, Fortis has been on a disciplined turnaround journey:
- Cleaned balance sheet
- Expanded hospital network
- Scaled diagnostics
- Focused on margin expansion
Fast forward to FY26.
Now we’re not talking about survival. We’re talking about expansion strategy, cluster dominance, robotic surgeries, oncology expansion, digital channels, and international patients.
But there’s a twist.
They’re expanding aggressively while trading at a premium valuation.
Is growth fast enough to justify the premium?
Or are investors already pricing in perfection?
Let’s dissect.
3. Business Model – WTF Do They Even Do?
Imagine Fortis as a three-headed healthcare hydra:
1️ Hospitals
Multi-specialty and super-specialty hospitals across key Indian cities. Revenue mainly from:
- Inpatient treatments
- Surgical procedures (62% of hospital revenue)
- Oncology, cardiac, neuro, ortho, renal, etc.
Occupancy ~67%.
ARPOB (Average Revenue Per Occupied Bed) ~₹2.56 Cr per annum.
They’re pushing complexity
